MAI Capital Management’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.64M | Sell |
847,553
-537,497
| -39% | -$2.94M | 0.03% | 342 |
|
|
2025
Q1 | $8.71M | Buy |
1,385,050
+28,164
| +2% | +$177K | 0.07% | 243 |
|
|
2024
Q4 | $5.59M | Buy |
1,356,886
+29,601
| +2% | +$122K | 0.04% | 310 |
|
|
2024
Q3 | $4.43M | Buy |
1,327,285
+8,789
| +0.7% | +$29.4K | 0.04% | 270 |
|
|
2024
Q2 | $3.93M | Buy |
1,318,496
+186,675
| +16% | +$556K | 0.04% | 288 |
|
|
2024
Q1 | $3.9M | Sell |
1,131,821
-147,637
| -12% | -$509K | 0.04% | 283 |
|
|
2023
Q4 | $1.71M | Sell |
1,279,458
-171,942
| -12% | -$230K | 0.02% | 344 |
|
|
2023
Q3 | $3.16M | Sell |
1,451,400
-83,252
| -5% | -$181K | 0.05% | 233 |
|
|
2023
Q2 | $3.67M | Sell |
1,534,652
-65,763
| -4% | -$157K | 0.05% | 218 |
|
|
2023
Q1 | $2.96M | Sell |
1,600,415
-120,261
| -7% | -$222K | 0.05% | 232 |
|
|
2022
Q4 | $3.32M | Sell |
1,720,676
-298,488
| -15% | -$576K | 0.06% | 213 |
|
|
2022
Q3 | $3.11M | Sell |
2,019,164
-20,845
| -1% | -$32.1K | 0.06% | 206 |
|
|
2022
Q2 | $5.73M | Buy |
2,040,009
+498,538
| +32% | +$1.4M | 0.11% | 148 |
|
|
2022
Q1 | $3.39M | Buy |
+1,541,471
| New | +$3.39M | 0.06% | 190 |
|